Identification of Patient Important Outcomes in Lung Transplantation
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Sep 27, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand what outcomes matter most to patients who have undergone lung transplantation. Lung transplants are critical for people suffering from severe respiratory issues, but the experience can be overwhelming for both patients and their families. The researchers want to hear from patients, their close relatives, and healthcare professionals to identify key aspects of care that truly impact the quality of life, such as pain management, mobility, and independence.
To participate in this study, you must be a lung transplant patient or a close family member of one, and you should be receiving care at specific hospitals in France. Medical staff who work closely with lung transplant patients are also eligible. The study will use a method called the Delphi method, which involves collecting anonymous opinions from experts to reach a consensus on the most important patient outcomes. By gathering this information, the researchers aim to create a set of core outcomes that can guide future studies and improve lung transplant care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Lung transplant patients followed at Bichat Hospital (Paris) or Foch Hospital (Suresnes).
- • Close relatives of lung transplant patients (spouse; partner; first-degree parent) followed at Bichat Hospital (Paris) or Foch Hospital (Suresnes).
- • Physicians from lung transplant centers in France, or French-speaking experts identified in the professional network of investigators.
- • Paramedical staff (state certified nurses, psychologists, physiotherapists, etc.) from the same French center or French-speaking centers whose primary focus is on caring for lung transplant patients.
- Exclusion Criteria:
- • Patients or close relatives under guardianship or protective supervision.
- • Minor patients or minor close relatives.
- • Patients or close relatives of recently transplanted patients (immediate post-transplant hospitalization).
- • Patients or close relatives of patients who have undergone a combined transplant (liver-lung, heart-lung, kidney-lung).
- • Non-comprehension of the French language.
- • Inability to use computer tools.
- • Refusal to participate.
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
WEISENBURGER Gaëlle, MD
Principal Investigator
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS-Hôpital Bichat
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported